Editorial: Perioral dermatitis.
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001623:Betamethasone / Q000009:adverse effects; D002648:Child; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology*; D005148:Facial Dermatoses / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D007223:Infant; D008297:Male; D010118:Oxytetracycline / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D001623:Betamethasone; D010118:Oxytetracycline